Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Cardinal Health (CAH) concluded the recent trading session at $132.75, signifying a -0.35% move from its prior day's close.

Cardinal Health outpaces S&P 500 with strong growth in specialty pharmaceuticals. Read why CAH stock has limited upside ...

The board of Cardinal Health, Inc. ( NYSE:CAH ) has announced that it will pay a dividend of $0.5056 per share on ...

Stifel initiates coverage on CRNX, a clinical-stage pharmaceutical company focused on endocrine diseases and tumors.

UCF Celebrates the Arts, at the Dr. Phillips Center for the Performing Arts, features theater, music, lectures, art and kids’ ...

Cardinal Health Inc. closed 0.34% below its 52-week high of $133.67, which the company reached on March 21st.

Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC ...

The support for Fonseca turned the Miami Open into a carnival. Many more tournaments can expect a similar phenomenon.

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) shot up 8.9% during trading on Monday after JPMorgan Chase & Co. raised their price target on the stock from $44.00 to $50.00. JPMorgan ...

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) had its price target increased by equities researchers at JPMorgan Chase & ...

Cardinal Health, Inc. (CAH), headquartered in Dublin, Ohio, is a leading global healthcare solutions provider specializing in ...